These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24188864)

  • 21. An Atypical Case of Leishmaniasis Associated with Chronic Duodenitis in a Dog.
    Ayala I; Bernal LJ; Garcia-Martinez JD; Gomez MA; Navarro JA; Bernabe A
    J Am Anim Hosp Assoc; 2017; 53(2):101-106. PubMed ID: 28282232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
    Miró G; Oliva G; Cruz I; Cañavate C; Mortarino M; Vischer C; Bianciardi P
    Vet Dermatol; 2009 Oct; 20(5-6):397-404. PubMed ID: 20178476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.
    Miró G; Gálvez R; Fraile C; Descalzo MA; Molina R
    Parasit Vectors; 2011 Apr; 4():52. PubMed ID: 21489241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between paraoxonase 1 activity and high density lipoprotein concentration during naturally occurring babesiosis in dogs.
    Rossi G; Kuleš J; Rafaj RB; Mrljak V; Lauzi S; Giordano A; Paltrinieri S
    Res Vet Sci; 2014 Oct; 97(2):318-24. PubMed ID: 25104322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.
    Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E
    J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of meglumine antimoniate in canine leishmaniasis.
    Lamothe J
    Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
    [No Abstract]   [Full Text] [Related]  

  • 28. Hair parasite load as a new biomarker for monitoring treatment response in canine leishmaniasis.
    Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Morillas-Márquez F; Martín-Sánchez J
    Vet Parasitol; 2016 Jun; 223():20-5. PubMed ID: 27198771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute phase protein response in experimental canine leishmaniasis.
    Martinez-Subiela S; Strauss-Ayali D; Cerón JJ; Baneth G
    Vet Parasitol; 2011 Aug; 180(3-4):197-202. PubMed ID: 21511399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment.
    Cantos-Barreda A; Escribano D; Martínez-Subiela S; Pardo-Marín L; Segarra S; Cerón JJ
    Vet Immunol Immunopathol; 2018 Apr; 198():65-69. PubMed ID: 29571520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of leishmanial osteolytic lesions in a hypothyroid dog by partial tarsal arthrodesis.
    Franch J; Pastor J; Torrent E; Lafuente P; Diaz-Bertrana MC; Munilla A; Durall I
    Vet Rec; 2004 Oct; 155(18):559-62. PubMed ID: 15559422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosis.
    Escribano D; Tvarijonaviciute A; Kocaturk M; Cerón JJ; Pardo-Marín L; Torrecillas A; Yilmaz Z; Martínez-Subiela S
    Comp Immunol Microbiol Infect Dis; 2016 Dec; 49():82-87. PubMed ID: 27865270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin.
    Rossi G; Giordano A; Pezzia F; Kjelgaard-Hansen M; Paltrinieri S
    Vet Clin Pathol; 2013 Sep; 42(3):329-41. PubMed ID: 23944371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extranodal gammadelta-T-cell lymphoma in a dog with leishmaniasis.
    Foglia Manzillo V; Pagano A; Guglielmino R; Gradoni L; Restucci B; Oliva G
    Vet Clin Pathol; 2008 Sep; 37(3):298-301. PubMed ID: 18761522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel biomarkers for treatment monitoring in canine leishmaniosis by high-resolution quantitative proteomic analysis.
    Martinez-Subiela S; Horvatic A; Escribano D; Pardo-Marin L; Kocaturk M; Mrljak V; Burchmore R; Ceron JJ; Yilmaz Z
    Vet Immunol Immunopathol; 2017 Sep; 191():60-67. PubMed ID: 28895868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
    Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Canine leishmaniasis in Spain: data for the clinician].
    Ferrer L
    Enferm Infecc Microbiol Clin; 1989; 7(6):293-5. PubMed ID: 2490443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.